36F79726D0208.docx

This is an Award Notice for a Schedule 65 indefinite-delivery/indefinite-quantity (IDIQ) contract awarded to Wilshire Pharmaceuticals, Inc. by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 (VISN 12). The contract was awarded on September 29, 2026, with a total contract value of $27,200,000 and an effective period of five years, from September 29, 2026, through September 28, 2031. The contract number is 36F79726D0208, and the solicitation number is M5Q50A03R8.

The contract establishes a vehicle for the provision of pharmaceutical products and services under the General Services Administration (GSA) Schedule 65 program, enabling the VA to order pharmaceuticals on an as-needed basis throughout the contract period. As an IDIQ contract, the actual quantities and delivery schedules will be determined by the VA's requirements during the contract term. The award represents a competitive procurement process resulting in the selection of Wilshire Pharmaceuticals as the contractor to supply pharmaceutical products to support the VA's healthcare operations within VISN 12.